Drug Type Small molecule drug |
Synonyms 2,4,5-trimethyl-N-[1-(methylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl]benzenesulfonamide |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H24N2O4S2 |
InChIKeyOEPGCHQKBHCJML-UHFFFAOYSA-N |
CAS Registry946352-47-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis | Preclinical | China | 31 May 2021 |